FDA puts two Chinese API makers on import alert after failed inspectionsnews2025-02-11T18:24:55+00:00February 11th, 2025|Endpoints News|
Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers news2025-02-10T18:22:08+00:00February 10th, 2025|Endpoints News|
Belgian regulator recommends blocking Indian drugmaker’s API productionnews2025-02-07T18:17:14+00:00February 7th, 2025|Endpoints News|
AstraZeneca cuts UK funding pledge; Viking says it has ‘enough’ API for trialsnews2025-02-06T16:52:23+00:00February 6th, 2025|Endpoints News|
Updated: Novo Nordisk sees growth slowing this year, plans CagriSema filing for 2026news2025-02-05T11:33:08+00:00February 5th, 2025|Endpoints News|
Bavarian Nordic’s stock sinks after 2024 revenues underwhelmnews2025-02-04T14:00:08+00:00February 4th, 2025|Endpoints News|
Charles River to shut down North Carolina pathology facilitynews2025-02-03T17:53:12+00:00February 3rd, 2025|Endpoints News|
Thermo Fisher to lay off 300 workers at two viral vector factories news2025-02-03T16:17:10+00:00February 3rd, 2025|Endpoints News|
Drug prices likely to soar due to Trump tariffs, pharma bodies warnnews2025-02-03T11:57:24+00:00February 3rd, 2025|Endpoints News|
J&J’s Rybrevant gets CHMP backing weeks after FDA rejectionnews2025-02-03T11:55:40+00:00February 3rd, 2025|Endpoints News|
